Neuphoria Therapeutics Inc. (NEUP)

CIK 1191070 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Neuphoria Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Jul 28, 2026SCHEDULE 13G/A0001104659-26-087379
Jul 24, 2026DEFA14A0001213900-26-081054
Jul 24, 20268-K0001213900-26-081052
May 26, 20268-K0001213900-26-061028
May 15, 202610-Q0001193125-26-225442
Feb 17, 202610-Q0001193125-26-054509
Feb 6, 2026SCHEDULE 13G/A0001957912-26-000007
Jan 21, 202640001213900-26-006172
Jan 21, 202640001213900-26-006173
Jan 21, 202640001213900-26-006171
Jan 21, 202640001213900-26-006170
Jan 8, 20268-K0001213900-26-002245
Dec 29, 2025SCHEDULE 13D/A0000905148-25-004490
Dec 18, 20258-K0001213900-25-123289
Dec 17, 20258-K0001213900-25-122777
Dec 8, 2025DEFA14A0001213900-25-119241
Dec 8, 2025DFAN14A0001193125-25-311358
Dec 8, 2025DFAN14A0001193125-25-311436
Dec 4, 2025DEFA14A0001213900-25-118291
Dec 3, 2025DFAN14A0001193125-25-305885
Dec 2, 2025SCHEDULE 13D/A0000905148-25-004208
Dec 2, 2025DFAN14A0001193125-25-305468
Dec 1, 2025DEFA14A0001213900-25-116694
Nov 28, 2025SCHEDULE 13D/A0000905148-25-004191
Nov 26, 2025DFAN14A0001193125-25-300651